AKTS Q1 2026 Earnings EPS Miss as PreRevenue Biotech Advances Pipeline SPG Q1 2026 Earnings Modest EPS Miss Amid Stable Operational Performance YELP Q1 2026 Earnings EPS Beat by 117 Amid Modest Stock Uptick Alumis Inc ALMS Q1 2026 Earnings Narrower Loss Mirrors Operational Discipline PreRevenue Stage Persists First Hawaiian Inc FHB Q1 2026 Earnings EPS Surpasses Estimates Amid Steady Operations Armata Pharmaceuticals ARMP Q1 2026 Earnings Massive EPS Miss as PreRevenue Biotech Struggles with Costs